Can a simple survey improve End-of-Life conversations for cancer patients?
NCT ID NCT06955468
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tested whether a short survey can help hospitalized patients with advanced lung or gastrointestinal cancers discuss their goals and preferences with their oncologist after leaving the hospital. The survey asks about treatment goals and understanding of the disease, and the results are shared with the care team. The study enrolled 40 patients and measured how often goals-of-care conversations were documented in medical records within 30 days.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Priming Survey (behavioral intervention)
- What this could lead to
- If successful, this approach could help ensure cancer patients receive care that matches their personal preferences and goals.
- What could go wrong
- This is a small pilot study focused on feasibility, not on proving that the intervention improves outcomes. It may not work in larger or more diverse groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL CANCERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can bright light help lung cancer patients sleep better and age slower?
- New platform aims to personalize cancer treatment for GI patients
- Could some GI cancer patients avoid major surgery? new study explores organ preservation
- Could silkworm pupas be the key to fighting muscle loss in cancer survivors?
- New hope for stomach and bowel cancers: experimental drug Rina-S enters Mid-Stage trial
- Simple blood test could spot lung cancer early in heavy smokers